plnh20250331

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

	OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number: 000-56374

	PLANET 13 HOLDINGS INC.
	(Exact name of Registrant as Specified in its Charter)

Nevada		83-2787199
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

2548 West Desert Inn Road, Suite 100 Las Vegas, Nevada		89109
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (702) 815-1313

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: Common Stock

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 14, 2025, there were 325,363,800 shares of common stock outstanding.

Table of Contents

true

Planet 13 Holdings Inc.

Quarterly Report on Form 10-Q

For Quarterly Period Ended March 31, 2025

Table of Contents

		Page
PART I	FINANCIAL INFORMATION
Item 1.	Financial Statements.	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	33
Item 4.	Controls and Procedures.	33


PART II	OTHER INFORMATION
Item 1.	Legal Proceedings.	34
Item 1A.	Risk Factors.	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	34
Item 3.	Defaults Upon Senior Securities.	34
Item 4.	Mine Safety Disclosures.	34
Item 5.	Other Information.	34
Item 6.	Exhibits.	35
SIGNATURES		36

Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q includes “forward-looking information” and “forward-looking statements” within the meaning of applicable United States securities laws and Canadian securities laws. All information, other than statements of historical facts, included in this Quarterly Report on Form 10-Q that addresses activities, events or developments that we expect or anticipate will or may occur in the future is forward-looking information. Forward-looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions and includes, among others, information regarding: our strategic plans and expansion and expectations regarding the growth of the California, Florida and Illinois cannabis markets; statements relating to the business and future activities of, and developments related to, us after the date of this Quarterly Report on Form 10-Q, including such things as future business strategy, competitive strengths, goals, expansion and growth of our business, operations and plans, new revenue streams, the completion by us of contemplated acquisitions of additional real estate, cultivation and licensing assets, the roll out of new dispensaries, the application for additional licenses and the grant of licenses or renewals of existing licenses that have been applied for, the expansion of existing cultivation and production facilities, the completion of cultivation and production facilities that are under construction, the construction of additional cultivation and production facilities, the expansion into additional U.S. markets, any potential future legalization of adult-use and/or medical cannabis under U.S. federal law; expectations of market size and growth in the United States and the states in which we operate or contemplate future operations; expectations for other economic, business, regulatory and/or competitive factors related to us or the cannabis industry generally; and other events or conditions that may occur in the future.

Table of Contents

Readers are cautioned that forward-looking information and statements are not based on historical facts but instead are based on reasonable assumptions and estimates of our management at the time they were provided or made and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, as applicable, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information and statements. Such factors include, among others, our actual financial position and results of operations differing from management’s expectations; our business model; a lack of business diversification; increasing competition in the industry; public opinion and perception of the cannabis industry; expected significant costs and obligations; current reliance on limited jurisdictions; development of our business; access to capital; risks relating to the management of growth; risks inherent in an agricultural business; risks relating to energy costs; risks related to research and market development; risks related to breaches of security at our facilities; reliance on suppliers; risks relating to the concentrated voting control of the Company; risks related to our being a holding company; risks related to service providers withdrawing or suspending services under threat of prosecution; risks related to proprietary intellectual property and potential infringement by third parties; risks of litigation relating to intellectual property; negative clinical trial results; insurance related risks; risk of litigation generally; risks associated with cannabis products manufactured for human consumption, including potential product recalls; risks relating to being unable to attract and retain key personnel; risks relating to obtaining and retaining relevant licenses; risks relating to integration of acquired businesses; risks related to quantifying our target market; risks related to industry growth and consolidation; fraudulent activity by employees, contractors and consultants; cyber-security risks; conflicts of interest; risks related to reputational damage in certain circumstances; leased premises risks; risks related to the COVID-19 pandemic; U.S. regulatory landscape and enforcement related to cannabis, including political risks; heightened scrutiny by Canadian regulatory authorities; risks related to capital raising due to heightened regulatory scrutiny; risks related to tax liabilities; risks related to U.S. state and local law and regulations; risks related to access to banks and credit card payment processors; risks related to potential violation of laws by banks and other financial institutions; ability and constraints on marketing products; risks related to lack of U.S. federal trademark and patent protection; risks related to the enforceability of contracts; the limited market for our securities; difficulty for U.S. holders of our common stock to resell over the Canadian Securities Exchange; price volatility of our common stock; future sales by shareholders; no guarantee regarding use of available funds; currency fluctuations; risks related to entry into the U.S; and other factors beyond our control, as more particularly described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent reports.

Readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions which may have been used. Although we have attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such forward-looking information and statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such information and statements. Accordingly, readers should not place undue reliance on forward-looking information and statements. The forward-looking information and statements contained herein are presented for the purposes of assisting readers in understanding our expected financial and operating performance and our plans and objectives and may not be appropriate for other purposes.

The forward-looking information and statements contained in this Quarterly Report on Form 10-Q represent our views and expectations as of the date of this Quarterly Report on Form 10-Q. We anticipate that subsequent events and developments may cause our views to change. However, while we may elect to update such forward-looking information and statements at a future time, we have no current intention of doing so except to the extent required by applicable law.

ADDITIONAL INFORMATION

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “we,” “us,” “our,” “Company,” or “Planet 13” refer to Planet 13 Holdings Inc. together with its wholly-owned subsidiaries.

Unless otherwise indicated, all references to “$,” “US$” or “USD” in this Quarterly Report on Form 10-Q refer to United States dollars, and all references to “C$,” “CAD$,” or “CAD” refer to Canadian dollars.

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

PLANET 13 HOLDINGS INC.

Interim Condensed Consolidated Balance Sheets

(Unaudited, In United States Dollars)

	*March 31,*			December 31,
	*2025*			2024
ASSETS
Current Assets:
Cash	$	15,556,553		$	23,384,493
Restricted Cash		2,050,584			2,050,584
Accounts Receivable		1,634,120			1,473,156
Inventory		24,199,619			22,821,994
Assets held for sale		4,570,227			-
Prepaid Expenses and Other Current Assets		3,714,748			4,568,816
Total Current Assets		51,725,851			54,299,043

Property, Plant and Equipment		63,223,161			63,511,423
Intangible Assets and Goodwill		48,763,931			48,763,931
Right of Use Assets - Operating		37,720,488			38,229,399
Long-term Deposits and Other Assets		1,068,477			1,033,758
Deferred Tax Asset		1,283,906			896,525

TOTAL ASSETS	$	203,785,814		$	206,734,079

LIABILITIES AND SHAREHOLDERS' EQUITY
LIABILITIES
Current:
Accounts Payable	$	5,940,241		$	7,421,921
Accrued Expenses		7,372,088			7,285,415
Income Taxes Payable		1,211,082			139,480
Notes Payable - Current Portion		8,847,542			8,681,684
Operating Lease Liabilities		1,897,526			1,818,588
Total Current Liabilities		25,268,479			25,347,088

Long-Term Liabilities:
Operating Lease Liabilities		46,006,886			46,448,666
Other Long-term Liabilities		1,230,037			1,220,722
Uncertain Tax Positions		19,321,475			19,321,475
Deferred Tax Liability		1,231,852			1,682,207
Total Liabilities		93,058,729			94,020,158

SHAREHOLDERS' EQUITY
Common Stock, no par value, 1,500,000,000 shares authorized, 325,263,800 issued and outstanding at March 31, 2025 and 325,163,800 issued and outstanding at December 31, 2024		-			-
Preferred Stock, no par value, 50,000,000 shares authorized, 0 issued and outstanding at March 31, 2025 and 0 at December 31, 2024		-			-
Additional Paid-In Capital		368,881,670			368,821,339
Deficit		(258,154,585	)		(256,107,418	)
Total Shareholders' Equity		110,727,085			112,713,921

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$	203,785,814		$	206,734,079

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

Table of Contents

PLANET 13 HOLDINGS INC.

Interim Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited, in United States Dollars, except Share Amounts)

	*Three Months Ended*
	*March 31,*			March 31,
	*2025*			2024

Revenues, net of discounts	$	28,031,807		$	22,877,471
Cost of Goods Sold		(16,024,302	)		(12,392,992	)
Gross Profit		12,007,505			10,484,479

Expenses:
General and Administrative		14,016,688			10,024,787
Sales and Marketing		1,547,018			1,290,737
Lease Expense		1,304,893			774,946
Depreciation		1,751,430			2,059,023
Total Expenses		18,620,029			14,149,493

Loss From Operations		(6,612,524	)		(3,665,014	)

Other Income (Expense):
Interest income (expense), net		(176,411	)		24,562
Foreign exchange (loss)		(2,889	)		(3,097	)
Other income, net		4,978,523			113,749
Total Other Income		4,799,223			135,214

Loss Before Provision for Income Taxes		(1,813,301	)		(3,529,800	)

Provision For Income Taxes
Current Tax Expense		(1,071,602	)		(2,363,860	)
Deferred Tax Recovery		837,736			19,891
		(233,866	)		(2,343,969	)

Net Loss and Comprehensive Loss	$	(2,047,167	)	$	(5,873,769	)

Loss per Share
Basic and diluted loss per share	$	(0.01	)	$	(0.03	)

Weighted Average Number of Shares of Common Stock
Basic and diluted		325,261,578			228,437,545

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

Table of Contents

PLANET 13 HOLDINGS INC.

Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity

(Unaudited, in United States Dollars, except Share Amounts)

	*Number of*
	*Shares of Common Stock*		*Warrants*		*Additional Paid-in Capital*			*Accumulated Deficit*			*Total Shareholders' Equity*

Balance, December 31, 2023		223,317,270		-	$	315,951,343		$	(208,310,562	)	$	107,640,781

Share based Compensation - RSUs		-		-		104,338			-			104,338
Share based Compensation - RSUs - Taxes Paid in Lieu of Share Issuance		-		-		(45,833	)		-			(45,833	)
Shares Issued on Settlement of RSUs		1,224,278		-		-			-			-
Proceeds from public offering		18,750,000		18,750,000		11,250,000			-			11,250,000
Share issuance costs		-		-		(1,336,144	)		-			(1,336,144	)
Net Loss for the Period		-		-		-			(5,873,769	)		(5,873,769	)

Balance, March 31, 2024		243,291,548		18,750,000	$	325,923,704		$	(214,184,331	)	$	111,739,373

Balance, December 31, 2024		325,163,800		18,750,000	$	368,821,339		$	(256,107,418	)	$	112,713,921

Share based Compensation - RSUs		-		-		60,331			-			60,331
Shares Issued on Settlement of RSUs		100,000		-		-			-			-
Net Loss for the Period		-		-		-			(2,047,167	)		(2,047,167	)

Balance, March 31, 2025		325,263,800		18,750,000	$	368,881,670		$	(258,154,585	)	$	110,727,085

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

Table of Contents

PLANET 13 HOLDINGS INC.

Interim Condensed Consolidated Statements of Cash Flows

(Unaudited, In United States Dollars)

	*Three Months Ended*
	*March 31,*			March 31,
	*2025*			2024
CASH USED IN OPERATING ACTIVITIES
Net loss	$	(2,047,167	)	$	(5,873,769	)
Adjustments for items not involving cash:
Shared based compensation		60,331			104,338
Non-cash lease expense		506,530			235,980
Depreciation		3,081,283			3,017,720
Loss on disposal of fixed assets		-			66,178
Recovery of property in legal settlement		(4,570,227	)		-
Amortization of note payable discount		126,725			-
Lease incentive amortization		2,381			27,277
		(2,840,144	)		(2,422,276	)

Net Changes in Non-cash Working Capital Items		(1,986,054	)		1,082,151
Repayment of lease liabilities		(362,842	)		(90,826	)
Total Operating		(5,189,040	)		(1,430,951	)

FINANCING ACTIVITIES
Proceeds from public share issuance		-			9,913,856
Repayment of Lafayette State Bank Note		(2,947,632	)		-
Bank of Nevada Revolving Line of Credit		3,000,000			-
Total Financing		52,368			9,913,856

INVESTING ACTIVITIES
Purchase of property and equipment		(2,691,268	)		(2,947,190	)
Proceeds from sales of fixed assets		-			4,594
Total Investing		(2,691,268	)		(2,942,596	)

NET CHANGE IN CASH DURING THE PERIOD		(7,827,940	)		5,540,309

CASH
Beginning of Period		25,435,077			17,281,592

End of Period	$	17,607,137		$	22,821,901

Supplemental cash flow information (Note 14)

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

1. Nature of Operations

Planet 13 Holdings Inc. (“P13” or the “Company”) was incorporated under the Canada Business Corporations Act on April 26, 2002 and continued under the British Columbia Business Corporations Act on September 24, 2019, and on September 15, 2023 completed its domestication to Nevada.

The Company is a vertically integrated cultivator and provider of cannabis and cannabis-infused products that is licensed under the laws of the States of Nevada, California, Illinois and Florida. The Company is licensed in these jurisdictions as follows: six Nevada licenses for cultivation (three medical and three adult-use), six Nevada licenses for production (three medical and three adult-use), three Nevada dispensary licenses (one medical and two adult-use), two Nevada licenses for distribution (one active, one conditional), one medical and adult-use dispensary license in California, two distribution licenses in California, one event organizer license in California, one medium indoor cultivation license in California, one non-volatile manufacturing license in California, one Medical Marijuana Treatment Center license in Florida (unlimited medical dispensaries, cultivation and processing) and one adult-use dispensary license in Illinois.

P13 is a public company which is listed on the Canadian Securities Exchange (“CSE”) under the symbol PLTH and on the OTCQX exchange under the symbol “PLNH”.

The Company’s registered and head office address is 2548 W. Desert Inn Road, Suite 100, Las Vegas, NV 89109.

While cannabis and CBD-infused products are legal under the laws of several U.S. states (with varying restrictions applicable), the United States Federal Controlled Substances Act classifies all “marijuana” as a Schedule I drug, whether for medical or recreational use. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for use under medical supervision.

The federal government currently is prohibited from prosecuting businesses that operate in compliance with applicable state and local medical cannabis laws and regulations; however, this does not protect adult use cannabis. If the federal government changes this position, it would be financially detrimental to the Company.

2. Basis of Presentation

These unaudited condensed consolidated interim financial statements reflect the accounts of the Company and have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for all periods presented. Certain information and footnote disclosures normally included in the audited annual consolidated financial statements prepared in accordance with GAAP have been omitted or condensed. The information included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2024 included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. These unaudited interim condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments), which, in the opinion of management, are necessary for the fair presentation of the results for the interim periods presented. Interim results are not necessarily indicative of results for a full year.

These unaudited interim condensed consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will continue in operation for the foreseeable future and, accordingly, will be able to realize its assets and discharge its liabilities in the normal course of operations as they come due.

Failure to arrange adequate financing on acceptable terms and/or achieve profitability may have an adverse effect on the financial position, results of operations, cash flows and prospects of the Company. These unaudited interim condensed consolidated financial statements do not give effect to adjustments to assets or liabilities that would be necessary should the Company be unable to continue as a going concern. Such adjustments could be material.

These unaudited condensed consolidated interim financial statements were authorized for issuance by the Board of Directors of the Company on May 14, 2025.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

i)	Basis of consolidation

These accompanying unaudited condensed consolidated interim financial statements include the accounts of the Company and all subsidiaries. Subsidiaries are entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest entity. Subsidiaries are fully consolidated from the date control is transferred to the Company and are deconsolidated from the date control ceases. All intercompany accounts and transactions have been eliminated upon consolidation. The unaudited condensed consolidated interim financial statements include all the assets, liabilities, revenues, expenses and cash flows of the Company and its subsidiaries after eliminating intercompany balances and transactions.

These unaudited condensed consolidated interim financial statements include the accounts of the Company and the following entities which are subsidiaries of the Company:

Subsidiaries as at March 31, 2025	*Jurisdiction of Incorporation*	*Ownership Interest 2025*	*Ownership Interest 2024*	*Nature of Business*

MM Development Company, Inc.	Nevada, USA	100%	100%	Nevada license holding company; vertically integrated cannabis operations
BLC Management Company LLC	Nevada, USA	100%	100%	Management/holding company
LBC CBD LLC	Nevada, USA	100%	100%	CBD retail sales and marketing
Newtonian Principles Inc.	California, USA	100%	100%	California license holding company; cannabis retail sales
Crossgate Capital U.S. Holdings Corp.	Nevada, USA	100%	100%	Holding company for Next Green Wave, LLC
Next Green Wave, LLC	California, USA	100%	100%	California license holding company; cannabis cultivation and processing
Planet 13 Illinois, LLC	Illinois, USA	100%	49%	Illinois license holding company; cannabis retail sales
BLC NV Food, LLC	Nevada, USA	100%	100%	Holding company for By The Slice LLC
By The Slice, LLC	Nevada, USA	100%	100%	Restaurant and retail operations
Planet 13 Chicago, LLC	Illinois, USA	100%	100%	Holding company
Planet 13 Florida, Inc.	Florida, USA	0%	100%	Florida license holding company
Planet 13 Real Prop LLC	Florida, USA	100%	N/A	Holding company
Planet 13 Lifestyles LLC	Nevada, USA	100%	0%	Retail sales of apparel and accessories
VidaCann, LLC	Florida, USA	100%	0%	Florida license holding company
Planet 13 Innovations LLC	Nevada, USA	100%	0%	Intellectual property holding company
Estate of Las Palmas LLC	California, USA	100%	N/A	Real estate holdings company
Club One Three, LLC	Nevada, USA	100%	N/A	Inactive

ii)	Functional currency

These unaudited condensed consolidated interim financial statements are presented in U.S. Dollars (“USD”), which is the Company’s and its subsidiaries’ functional currency.

Foreign currency transactions are remeasured to the respective financial currencies of the Company’s entities at the exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies are measured to functional currency at the foreign exchange rate applicable at the statement of balance sheets date. Non-monetary items are carried at historical rates. Non-monetary items carried at face value denominated in foreign currencies are remeasured to the functional currency at the date when the fair value was determined. Realized and unrealized foreign exchange gains and losses are recognized through profit or loss.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

iii)	Emerging growth company

The Company is an “Emerging Growth Company”, as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it has taken advantage of certain exemptions that are not applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not has a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial reporting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable.

The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public and private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

3. Inventory

Finished goods inventory consists of dried cannabis, concentrates, edibles, and other products that are complete and available for sale (both internally generated inventory and third-party products purchased in the wholesale market). Work in process inventory consists of cannabis after harvest, in the processing stage. Packaging and miscellaneous consist of consumables for use in the transformation of biological assets and other inventory used in the production of finished goods, non-cannabis merchandise and food and beverage items. The Company’s inventory is comprised of:

	*March 31,*		December 31,
	*2025*		2024

Raw materials	$	9,352,514	$	9,768,295
Packaging and miscellaneous		2,339,073		1,949,621
Work in progress		6,454,916		6,406,679
Finished goods		6,053,116		4,697,399
	$	24,199,619	$	22,821,994

Cost of Inventory is recognized as an expense when sold and included in the cost of goods sold. During the three months ended March 31, 2025, the Company recognized $16,024,302 (2024 - $12,392,992) of inventory expensed to cost of goods sold.

4. Prepaid Expenses and Other Current Assets

	*March 31,*		December 31,
	*2025*		2024

Security deposits	$	266,652	$	122,839
Advertising and Marketing		182,777		259,113
Prepaid rent		951,065		965,043
Insurance		419,457		414,570
License fees		971,505		1,211,694
Miscellaneous		923,292		1,595,557
	$	3,714,748	$	4,568,816

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

5. Property, Plant and Equipment

	*Land and*						*Leasehold*		*Construction*
	*Improvements*		*Buildings*		*Equipment*		*Improvements*		*in Progress*			*Total*
Gross carrying amount

At December 31, 2024	$	6,065,961	$	17,088,552	$	17,041,131	$	65,353,357	$	2,958,787		$	108,507,788
Additions		-		11,470		334,137		530,290		1,917,124			2,793,021
Transfers		-		-		289,903		1,767,507		(2,057,410	)		-
At March 31, 2025	$	6,065,961	$	17,100,022	$	17,665,171	$	67,651,154	$	2,818,501		$	111,300,809

Depreciation

At December 31, 2024	$	28,472	$	1,321,972	$	10,211,536	$	33,434,385	$	-		$	44,996,365
Additions		5,546		190,864		636,195		2,248,678		-			3,081,283
At March 31, 2025	$	34,018	$	1,512,836	$	10,847,731	$	35,683,063	$	-		$	48,077,648

Carrying amount

At December 31, 2024	$	6,037,489	$	15,766,580	$	6,829,595	$	31,918,972	$	2,958,787		$	63,511,423
At March 31, 2025	$	6,031,943	$	15,587,186	$	6,817,440	$	31,968,091	$	2,818,501		$	63,223,161

For the three months ended March 31, 2025, depreciation expense was $3,081,283 (2024 - $3,017,720) of which $1,329,853 (2024 - $958,697) was included in cost of goods sold and inventory.

During the three months ended March 31, 2025, $2,057,410 was transferred from Construction in Progress to the other fixed accounts (2024 - $0).

During the three months ended March 31, 2025, no impairment charges were recognized. (2024 - $0).

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

6. Intangible Assets

	*Retail Dispensary Clark County*		*Cultivation and Production Clark County*		*Illinois License*		*Cultivation Coalinga CA Other Intangibles*		*Florida MMTC License-VidaCann*		*VidaCann Goodwill*		*Other*		*Total*
Gross carrying amount

Balance, December 31, 2024	$	690,000	$	709,798	$	1,812,656	$	5,860,000	$	9,000,000	$	30,661,477	$	30,000	$	48,763,931
Additions		-		-		-		-		-		-		-		-
Balance at March 31, 2025	$	690,000	$	709,798	$	1,812,656	$	5,860,000	$	9,000,000	$	30,661,477	$	30,000	$	48,763,931

VidaCann Acquisition

On August 28, 2023, the Company entered into a Membership Interest Purchase Agreement (“Purchase Agreement”) with VidaCann, LLC (“VidaCann”), Loop’s Dispensaries, LLC (“Dispensaries”), Ray of Hope 4 Florida, LLC (“Ray of Hope”) and Loops Nursery & Greenhouses, Inc. (“Nursery” and together with Dispensaries and Ray of Hope, the (“Sellers”), David Loop (“Loop”) and Mark Ascik and Loop, solely in his capacity as Seller Representative, pursuant to which, upon the terms and subject to the conditions set forth therein, the Company acquired from the Sellers all of the membership interests in VidaCann (the “Transaction”).

On May 9, 2024, the Company acquired 100% ownership interest of VidaCann, and accounted for the Transaction as a business combination acquisition pursuant to ASC 805.

Pursuant to the Purchase Agreement, the Company acquired VidaCann from the Sellers for agreed consideration at closing of the Transaction (the “Closing”) equal to the sum of: (i) 80,564,554 shares of common stock of the Company (the “Base Share Consideration”), plus 1,307,698 shares with a fair value of $750,000 that were issued to VidaCann’s industry advisor as acquisition-related costs; (ii) a cash payment of $4,000,000 (the “Closing Cash Payment”); and (iii) promissory notes issued by the Company to the Sellers in the aggregate principal amount of $5,000,000, with each of the above components subject to adjustments as set out in the Purchase Agreement. Based on the closing price of the Company’s common stock of (CAD$0.9100) $0.6647 on May 9, 2024 on the Canadian Securities Exchange (the “CSE”) (based on the Bank of Canada CAD to USD exchange rate on May 9, 2024 of CAD$1.00=$0.7304), the total consideration was valued at $50,755,443. As contemplated by the Purchase Agreement, VidaCann continued to have $3 million of bank indebtedness and $1.5 million of related party notes to former VidaCann managers at the time of closing, which were assumed by the Company. The Seller of the majority interest in VidaCann also had the right to nominate a director to the Company’s board of directors effective the next business day following the Company’s 2024 annual meeting of stockholders and selected David Loop, the former Chief Executive Officer of VidaCann, as its board nominee.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

The VidaCann acquisition was deemed to be a business combination under ASC 805. The following table summarizes the allocation of consideration exchanged to the estimated fair value of the tangible and intangible assets acquired:

Consideration paid:

Cash	$	4,000,000
Issuance of 80,564,554 shares of common stock		42,123,314
Note Payable to Former VidaCann Shareholders		4,632,129
	$	50,755,443

Fair value of net assets acquired:

Cash	$	911,715
Inventory		7,375,225
Prepaids and other assets		1,869,222
Property, plant and equipment		9,080,072
ROU Assets		21,371,614
Intangible assets		9,000,000
Goodwill		30,661,477
ROU Liabilities		(21,371,614	)
Notes Payable		(4,010,582	)
Accounts Payable and Accrued Liabilities		(4,131,686	)
	$	50,755,443

The purchase price allocations for the VidaCann transaction reflect various fair value estimates and analyses relating to the determination of fair value of certain tangible and intangible assets acquired and residual goodwill. The Company determined the estimated fair value of the acquired working capital, and identifiable intangible assets and goodwill after review and consideration of relevant information including market data and management’s estimates. The estimated fair value of acquired working capital was determined to approximate carrying value.

The goodwill arising from the VidaCann transaction consists of expected synergies from combining operations of the Company and VidaCann, and intangible assets not qualifying for separate recognition such as formulations, proprietary technologies and acquired know-how. None of the goodwill is deductible for tax purposes. VidaCann’s state cannabis license represented an identifiable intangible asset acquired in the amount of $9,000,000. The VidaCann cannabis license acquired has an indefinite life and as such will not be subject to amortization.

In connection with the VidaCann transaction, the Company expensed $0 of acquisition-related costs, which have been included in general and administrative expenses on the Company’s consolidated statement of operations and comprehensive loss for the period ended March 31, 2025, and $41,832 for the period ended March 31, 2024.

VidaCann contributed $9,389,471 in Net Revenue, $4,377,513 in Gross Profit, and a net loss of $1,450,580 in Consolidated Comprehensive Net Loss in the three-month period ended March 31, 2025.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

The following table reflects the revenue, gross profit and comprehensive loss that would have been reported if the acquisition had occurred at the beginning of the period indicated:

	Three Months Ended March 31, 2024
	As Reported			VidaCann		Pro Forma

Revenue, net of discounts	$	22,877,471		$	12,511,055	$	35,388,526
Gross Profit		10,484,479			5,572,033		16,056,512
Comprehensive Income (loss) for the period		(5,873,769	)		2,123,825		(3,749,944	)

Florida License

On January 22, 2024, the Company entered into a definitive agreement to sell its Planet 13 Florida, Inc. entity for $9,000,000 which, at the time of sale held no assets other than a Florida medical marijuana treatment center license (the “MMTC license”). The value of the MMTC license at December 31, 2023 was less than the carrying amount of the license. Consequently, the Company recorded an impairment charge of $46,846,866 against the carrying value of the MMTC license. The impairment loss is reflected in the statement of operations and comprehensive loss of the year ended December 31, 2023 under the caption “Impairment Loss”. During the fourth quarter of 2023, the Company committed to a plan to sell its Florida license. Accordingly, the license held by the Company's Florida subsidiary was presented as an asset held for sale on the consolidated balance sheet as of December 31, 2023. The sale of Planet 13 Florida, Inc. was completed on May 6, 2024. Transaction costs incurred for the sale of the license equaled $762,091.

7. Leases

The Company’s lease agreements are for cultivation, manufacturing, retail office premises and for vehicles. The property lease terms range between 5 years and 21 years depending on the facility and are subject to an average of 2 renewal periods of equal length as the original lease. Certain leases include escalation clauses or payment of executory costs such as property taxes, utilities, or insurance and maintenance. Rent expense for leases with escalation clauses is accounted for on a straight-line basis over the lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

The following table provides the components of lease costs recognized in the unaudited interim condensed consolidated statement of operations and comprehensive loss for the three-month periods ended March 31, 2025 and 2024:

	*Three Months Ended*
	*March 31,*		March 31,
	*2025*		2024

Operating lease costs	$	2,307,071	$	1,264,185
Short term lease expense		111,293		12,550
Total lease costs	$	2,418,364	$	1,276,735

Other information related to operating and finance leases as of and for the three months ended March 31, 2025 and 2024 is as follows:

	*March 31, 2025*			March 31, 2024
	*Operating*			Operating
	*Lease*			Lease

Weighted average discount rate		15.00	%		15.00	%
Weighted average remaining lease term		7.66			11.26

The maturities of the contractual undiscounted lease liabilities as of March 31, 2025 and December 31, 2024 are:

	*2025*			2024
	*Operating*			Operating
	*Lease*			Lease

2025	$	6,521,143		$	8,682,145
2026		8,750,185			8,750,185
2027		8,805,324			8,805,324
2028		8,934,274			8,934,274
2029		8,858,495			8,858,495
2030		8,109,104			8,109,104
2031		7,526,059			-
Thereafter		60,405,199			67,931,257

Total undiscounted lease liabilities		117,909,783			120,070,784
Interest on lease liabilities		(70,005,371	)		(71,803,530	)
Total present value of minimum lease payments		47,904,412			48,267,254
Lease liability - current portion		(1,897,526	)		(1,818,588	)
Lease liability	$	46,006,886		$	46,448,666

Principally all leases relate to real estate.

For the three months ended March 31, 2025, the Company incurred $2,307,071 of operating lease costs (2024 - $1,264,185), of which $1,016,521 (2024 - $489,239) was allocated to cost of goods sold and inventory.

See Note 14 for additional supplemental cash flow information related to leases.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

8. Notes Payable

	*March 31,*			December 31,			Stated Interest				Effective			Maturity
	*2025*			2024			Rate				Interest Rate			Date

Promissory note dated November 4, 2015, with semi-annual interest at 5.0%, secured by deed of trust, due December 1, 2019		884,000			884,000			5.0	%			5.0	%	12/1/2019
Promissory Note to Former VidaCann shareholders		4,963,542			4,869,695			5.0	%	⁽¹⁾		15.0	%	4/1/2025
Promissory Note to La Fayette State Bank		-			2,927,989			10.0	%	⁽²⁾		15.0	%	2/20/2025
Promissory Note to VidaCann former managers		1,190,957			1,177,722			7.5	%	⁽³⁾		15.0	%	5/6/2029
Revolving Line of Credit, cash secured with monthly interest paid at an annual rate of 5.84%		3,000,000			-			5.84	%	⁽⁴⁾		5.84	%	7/1/2025

	$	10,038,499		$	9,859,406
Less current portion		(8,847,542	)		(8,681,684	)
	$	1,190,957		$	1,177,722

Stated maturities of debt obligations are as follows:

2025	$	-		$	8,681,684
2026		8,847,542			-
2027		-			-
2028		-			-
2029		-			1,177,722
2030		1,190,957			-
Total	$	10,038,499		$	9,859,406

(1) The Promissory note to former VidaCann shareholders had a face value of $5,000,000. The Company determined a fair value of $4,632,129 at the May 9, 2024 acquisition date using a 15% estimated borrowing rate. Total interest expense including accrued interest and amortization of the note discount for the three-month period ended March 31, 2025 equaled $155,490 (2024 - $0).

(2) The Promissory note to Lafayette State Bank had a face value of $2,947,632. The Company determined a fair value of $2,862,159 at the May 9, 2024 acquisition date using a 15% estimated borrowing rate. Total interest expense including paid interest and amortization of the note discount for the three-month period ended March 31, 2025 equaled $49,119 (2024 - $0). This note was paid in full on February 11, 2025.

(3) The Promissory note to VidaCann former managers had a face value of $1,500,000. The Company determined a fair value of $1,148,423 at the May 9, 2024 acquisition date using a 15% estimated borrowing rate. Total interest expense including paid interest and amortization of the note discount for the three-month period ended March 31, 2025 equaled $68,715.

(4) The revolving line of credit balance at March 31, 2025 equaled $3,000,000. The Company entered into the revolving promissory note agreement effective June 13, 2024 for a cash secured credit line of up to $9,750,000. There are no covenants or other collateral secured by the credit line. Total interest expense for the three-month period ended March 31, 2025 equaled $0.

9. Share Capital

The Company is authorized to issue 1,500,000,000 shares of common stock and 50,000,000 shares of preferred stock.

		*Number of Shares of Common Stock*

		*March 31,*		December 31,
		*2025*		2024
Common Stock
Balance at January 1			325,163,800		223,317,270
Shares issued on settlement of RSUs	i.		100,000		1,224,278
Shares issued on public offering	ii.		-		18,750,000
Shares issued in VidaCann Acquisition	iii.		-		80,564,554
Finders shares issued on VidaCann acquisition	iv.		-		1,307,698

*Total shares of common stock outstanding*			325,263,800		325,163,800

i. Shares issued for Restricted Share Units

During the three months ended March 31, 2025, 100,000 RSUs were awarded and vested under the Planet 13 Holdings Inc 2023 Equity incentive plan (the "2023 Equity Plan"). The Company did not receive any cash proceeds on the settlement of the RSUs.

During the year ended December 31, 2024, 485,185 RSUs were awarded under the 2023 Equity Plan. 185,185 of these RSUs vested (of which 83,333 RSUs were surrendered in exchange for tax withholding payments), 1,224,278 of vested RSUs were settled and no RSUs were cancelled. The Company did not receive any cash proceeds on the settlement of the RSUs.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

ii. Shares issued on public offering

On March 7, 2024, the Company issued and sold 18,750,000 units of the Company (the “Units”) at a public offering price of $0.60 per unit (the "Offering"). Each Unit consisted of one share (each, a “Share”) of common stock, no par value, of the Company (“Common Stock”) and one warrant. Each warrant (a “Warrant”) entitles the holder to purchase one share of Common Stock for a period of 5 years following the closing date of the Offering at an exercise price of US$0.77, subject to adjustments in certain events. Total gross proceeds to the Company were approximately $11.3 million.

iii. Shares issued on VidaCann acquisition

On May 9, 2024, the Company issued 80,564,554 shares of common stock of Planet 13 (the “Share Consideration”).

iv. Finders shares issued on VidaCann acquisition

On May 9, 2024, the Company issued 1,307,698 shares of common stock of Planet 13 in finders shares related to the VidaCann acquisition.

10. Warrants

The following table summarizes the number of warrants outstanding at March 31, 2025 and December 31, 2024.

	*March 31, 2025*		*Weighted Average Exercise Price - USD*		*December 31, 2024*		*Weighted Average Exercise Price - USD*

Balance - beginning of period		18,750,000	$	0.77		-	$	-
Exercised		-	$	-		-	$	-
Issued		-	$	-		18,750,000	$	0.77
Expired		-	$	-		-	$	-
Balance - end of period		18,750,000	$	0.77		18,750,000	$	0.77

On March 7, 2024, the Company issued and sold 18,750,000 Units at a public offering price of $0.60 per unit. Each Unit consisted of one share of Common Stock and one Warrant. Each Warrant entitles the holder to purchase one share of Common Stock for a period of 5 years following the closing date of the Offering at an exercise price of $0.77, subject to adjustments in certain events. The warrants expire on March 7, 2029.

11. Share Based Compensation

At the 2023 Annual General and Special Meeting, the shareholders of Planet 13 voted to approve and adopt the 2023 Equity Plan, which was contingent upon the completion of the Company's domestication, and became effective on September 15, 2023. As of September 15, 2023, the Company may not grant any new awards under the Planet 13 Holdings Inc. 2018 Stock Option Plan and Planet 13 Holdings Inc. 2018 Share Unit Plan (collectively, the “Prior Plans”), and the Prior Plans will continue to govern awards previously granted under them.

A total of 22,000,000 shares of Common Stock are available for grants under the 2023 Equity Plan and all other security based compensation arrangements of the Company, including the Prior Plans (the “Total Share Reserve”). Any outstanding awards under the Prior Plans on September 15, 2023 count towards the Total Share Reserve. As of September 15, 2023, 1,926,861 awards issued under the Prior Plans remained outstanding and, as of March 31, 2025, after taking into account the 13,776,345 RSUs granted on April 1, 2025 (see Note 20), a maximum number of 5,404,609 shares of Common Stock are available for issuance under the 2023 Equity Plan, subject to adjustment pursuant to the terms of the 2023 Equity Plan.

(a) Stock Options

During the three months ended March 31, 2025 and the year ended December 31, 2024

No incentive stock options were granted during the three months ended March 31, 2025 or the year ended December 31, 2024.

The following table summarizes information about stock options outstanding at March 31, 2025:

	*Exercise price*		*March 31, 2025*		*March 31, 2025*		*December 31, 2024*		*December 31, 2024*
Expiry Date		*CAD$*	*Outstanding*		*Exercisable*		*Outstanding*		*Exercisable*

February 27, 2025	$	1.31		-		-		51,525		51,525
December 15, 2025	$	3.06		269,075		269,075		269,075		269,075
September 30, 2026	$	4.37		97,322		97,322		97,322		97,322
				366,397		366,397		417,922		417,922

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

The following table reflects the continuity of stock options for the period presented:

	*March 31, 2025*			*Weighted Average Exercise Price - CAD*		December 31, 2024			Weighted Average Exercise Price - CAD

Balance - beginning of period		417,922		$	3.15		603,125		$	2.58
Expired		(51,525	)		1.31		(185,203	)		1.31
Balance - end of period		366,397		$	3.41		417,922		$	3.15

Share based compensation expense attributable to employee options was $0 and $0 for the three months ended March 31, 2025 and 2024, respectively.

The total intrinsic value of stock options exercised, outstanding and exercisable as of March 31, 2025 and December 31, 2024 was $0, $0 and $0, respectively.

(a) Restricted Share Units

The following table summarizes the RSUs that are outstanding as at March 31, 2025 and December 31, 2024:

	*March 31,*			December 31,
	*2025*			2024

Balance - beginning of period		300,000			1,122,429
Issued		100,000			485,185
Exercised		(100,000	)		(1,224,278	)
Surrendered for taxes		-			(83,333	)
Forfeited		-			-
Rounding adjustment		-			(3	)
Balance - end of period		300,000			300,000

The Company recognized $60,331 in share-based compensation expense attributable to the RSU vesting schedule for the three months ended March 31, 2025 ($104,338 for the three months ended March 31, 2024).

During the three months ended March 31, 2025

100,000 RSU's were granted, vested and were exercised. The Company did not receive any cash proceeds from the settlement of the RSUs.

During the three months ended March 31, 2024

485,185 RSU's were granted, and 185,185 RSUs vested and were exercised, of which 83,333 were surrendered in exchange for payment of tax withholdings. The Company did not receive any cash proceeds from the settlement of the RSUs.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

12. Loss Per Share

	*Three Months Ended*
	*March 31,*			March 31,
	*2025*			2024

Loss available to common stockholders	$	(2,047,167	)	$	(5,873,769	)

Weighted average number of shares outstanding, basic and diluted		325,261,578			228,437,545

Basic and diluted loss per share	$	(0.01	)	$	(0.03	)

19,416,397 and 19,653,125 potentially dilutive securities for the three months ended March 31, 2025 and 2024, respectively, were excluded in the calculation of diluted EPS as their impact would have been anti-dilutive due to the net losses for such periods.

13. General and Administrative

	*Three Months Ended*
	*March 31,*		March 31,
	*2025*		2024

Salaries and wages	$	5,878,604	$	3,665,242
Share based compensation	$	60,331		104,338
Executive compensation	$	1,099,940		632,362
Licenses and permits	$	702,036		561,616
Payroll taxes and benefits	$	1,387,489		973,275
Supplies and office expenses	$	329,597		240,820
Subcontractors	$	635,060		117,219
Professional fees (legal, audit and other)	$	1,263,506		2,171,039
Miscellaneous general and administrative expenses	$	2,660,125		1,558,876
	$	14,016,688	$	10,024,787

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

14. Supplemental Cash Flow Information

	*Three Months Ended*
	*March 31,*			March 31,
Change in Working Capital	*2025*			2024

Accounts Receivable	$	(160,964	)	$	160,462
Inventory		(1,377,625	)		(1,238,177	)
Prepaid Expenses and Other Assets		854,068			1,179,543
Long-term Deposits and Other Current Assets		(34,719	)		69,096
Deferred Tax Assets		(387,381	)		(19,158	)
Deferred Tax Liabilities		(450,355	)		(733	)
Accounts Payable		(1,583,433	)		(829,695	)
Accrued Expenses		86,673			(956,061	)
Other Liabilities (LT)		(3,920	)		-
Income Taxes Payable		1,071,602			2,716,874
	$	(1,986,054	)	$	1,082,151

Cash Paid

Interest Paid on Leases	$	1,798,160		$	989,887
Income Taxes	$	-		$	7,540,000

Non-cash Financing and Investing Activities

Shares Issued on Exercise of Purchase Option	$	-		$	-
Lease additions	$	-		$	725,406
Fixed Asset Amounts in Accounts Payable	$	420,470		$	16,089
Reclassification of long term lease liabilities to current	$	78,938		$	104,795

15. Related Party Transactions and Balances

Related party transactions are summarized as follows:

(a) Building Lease

As part of the VidaCann acquisition on May 9, 2024, the Company entered into a long-term lease agreement with Loop's Nursery for a property in St John's Florida that is used as the Company's primary cultivation facility in Florida. Loop's Nursery is primarily owned by David Loop, one of the Company's board members. Payments for rent and associated costs related to the use of this property for the three months ended March 31, 2025 equaled $922,111 (three months ended March 31, 2024 - $nil).

(b) Other

As part of the VidaCann acquisition on May 9, 2024, the Company acquired related party notes payable to David Loop, one of the Company's board members and Mark Ascik, in the amounts of $750,000 each (see Note 8). Payments for interest on the related party notes for the three months ended March 31, 2025 totaled $27,740 combined (three months ended March 31, 2024 - $nil).

Effective March 1, 2025, the Company entered into a 30 month lease agreement with PRMN Investments Ltd for a Florida apartment unit used primarily for executive travel in Florida for oversight of Florida operations. PRMN Investments Ltd is primarily owned by Robert Groesbeck, the Company's Co-CEO. Payments for rent and associated costs related to the use of this property for the three months ended March 31, 2025 equaled $5,099 (three months ended March 31, 2024 - $nil).

For the three-month period ended March 31, 2025, no amounts were due to related parties ( December 31, 2024 - $nil).

16. Commitments and Contingencies

(a) Construction Commitments

The Company had $312,770 of outstanding construction commitments as of March 31, 2025 ( December 31, 2024 - $786,490).

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

(b) Contingencies

The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company ceasing operations. While management of the Company believes that the Company is in compliance with applicable local and state regulations at March 31, 2025, medical and adult use cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties, or restrictions in the future.

(c) Claims and Litigation

From time to time, we may become involved in legal or regulatory proceedings, lawsuits and other claims arising in the ordinary course of our business. In view of the inherent difficulty of predicting the outcome of such matters, we cannot state what the eventual outcome of such matters will be. However, based on our knowledge, as of March 31, 2025, we are not presently a party to any legal proceedings that, in the opinion of our management, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity and reputational harm, and other factors.

(d) Operating Licenses

Although the possession, cultivation, and distribution of marijuana for medical and adult use is permitted in Nevada and California, and for medical use these activities are permitted in Florida, marijuana is a Schedule I controlled substance, and its use remains a violation of federal law. Since federal law criminalizing the use of marijuana pre-empts state laws that legalize its use, strict enforcement of federal law regarding marijuana would likely result in the Company’s inability to proceed with our business plans. In addition, the Company’s assets, including real property, cash, equipment, and other goods, could be subject to asset forfeiture because marijuana is still federally illegal.

17. Risks

Credit risk

Credit risk is the risk that a third party might fail to discharge its obligations under the terms of a financial instrument. Credit risk arises from cash with banks and financial institutions. It is management's opinion that the Company is not exposed to significant credit risk arising from these financial instruments. The Company limits credit risk by entering into business arrangements with high credit-quality counterparties. The Company further limits credit risk to a maximum of $500,000 to any individual counterparty at a given time. Total maximum credit risk for all counterparties combined is estimated at $1,500,000.

The Company evaluates the collectability of its accounts receivable and maintains an allowance for credit losses at an amount sufficient to absorb losses inherent in the existing accounts receivable portfolio as of the reporting dates based on the estimate of expected net credit losses.

Interest Rate Risk

Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company currently has some notes payable that are interest bearing, as well as funds held in an interest-bearing money market account. Based on the balances involved, it is management’s opinion that the Company is not exposed to significant interest rate risk.

Price risk

Price risk is the risk that the trading price of the Company’s shares will fluctuate and adversely impact the Company, primarily due to the inability to raise additional funds through future stock offerings. The Company is not exposed to significant price risk.

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

Liquidity risk

The Company’s approach to managing risk is to ensure that it will have sufficient liquidity to meet liabilities when due. As of March 31, 2025, the Company’s financial liabilities consist of accounts payable, accrued liabilities, obligations under operating leases, notes payable and taxes. The Company manages liquidity risk by reviewing its capital requirements on an ongoing basis. Historically, the Company’s main source of funding has been the public issuance of common equity. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity financing.

Concentration risk

The Company operates exclusively in Southern Nevada, Florida, and California and has a small presence in Illinois. Should economic conditions deteriorate within any of these regions, its results of operations and financial position would be negatively impacted.

Banking risk

Notwithstanding that a majority of states have legalized medical marijuana, there has been no change in US federal banking laws related to the deposit and holding of funds derived from activities related to the cannabis industry. Given that US federal law provides that the production and possession of cannabis is illegal, there is a strong argument that banks cannot accept or deposit funds from businesses involved with the marijuana industry. Consequently, businesses involved in the cannabis industry often have difficulty accessing the US banking system and traditional financing sources. The inability to open bank accounts with certain institutions may make it difficult to operate the business of the Company and leave the Company’s cash holdings vulnerable.

Asset forfeiture risk

Because the cannabis industry remains illegal under US federal law, any property owned by participants in the cannabis industry which are either used in the course of conducting such business, or are the proceeds of such business, could be subject to seizure by law enforcement and subsequent civil asset forfeiture. Even if the owner of the property was never charged with a crime, the property in question could still be seized and subject to an administrative proceeding by which with minimal due process, it could be subject to forfeiture.

Currency rate risk

As at March 31, 2025, none of the Company’s financial assets and liabilities were held in Canadian dollars (2024 - $0). The Company’s objective in managing its foreign currency risk is to minimize its net exposure to foreign currency cash flows by transacting, to the greatest extent possible, with third parties in the functional currency. The Company does not currently use foreign exchange contracts to hedge its exposure of its foreign currency cash flows as management has determined that this risk is not significant at this point in time. The Company’s exposure to a 10% change in the foreign exchange conversion rate at March 31, 2025 equals $nil.

18. Disaggregated Revenue

The following table presents the Company’s disaggregated revenue by sales channel:

	*Three Months Ended*
	*March 31,*		March 31,
	*2025*		2024

Retail	$	24,629,801	$	19,037,664
Wholesale		3,402,006		3,839,807

Net revenues	$	28,031,807	$	22,877,471

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

Table of Contents

PLANET 13 HOLDINGS INC.

Notes to the Interim Condensed Consolidated Financial Statements

(Unaudited, in United States Dollars, except share amounts)

19. Potential Acquisition

On July 31, 2024, the Company announced that its wholly-owned subsidiary, MM Development Company Inc., entered into an asset purchase agreement to acquire all assets required to operate a 3,158 square foot dispensary located in Las Vegas, Nevada, including fixtures, cannabis and non-cannabis inventory and other items contained within the proposed building and a medical and recreational license from Exhale Brands Nevada LLC (“Exhale”). Planet 13 agreed to pay $6.9 million plus the value of the cannabis inventory on closing. The payment was to be comprised of $4.0 million in cash payable at time of closing and $2.9 million (plus the value of the cannabis inventory at closing) payable in the form of a secured promissory note due a year from closing and secured by the assets being acquired. The Company notified Exhale of the termination of the agreement in January 2025 and does not expect the acquisition to move forward.

20. Property Recovered in Settlement

On March 3, 2025 the Company announced significant recovery of funds related to El Capitan, including a settlement and recovery of $2.1 million of funds which were held at Bridge Bank, a division of Western Alliance Bank (collectively "WAB"), bringing the total recovery of funds held at WAB to $5.5 million. Additionally, the Company, through a wholly-owned subsidiary, will also obtain real estate (the "Real Property") valued at approximately $5.0 million based on recent comparable sales, which it intends to sell. The property is included in Assets Held For Sale on the Interim Condensed Consolidated Balance Sheet at March 31, 2025 at a net value (after estimated costs to sell) of $4.6 million. The recovery amount is also included in the Interim Condensed Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2025 in Other income, net and also in the Interim Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 in Adjustments for items not involving cash, Recovery of property in legal settlement.

21. Subsequent Events

On April 1, 2025 the Company paid off the full balance owed on the former VidaCann shareholder note issued in conjunction with the acquisition of VidaCann, LLC on May 9, 2024. The total amount paid included $5,000,000 in principal and $223,288 of accrued interest.

On April 1, 2025 the Company announced that it granted RSUs to certain of its officers, directors and employees after market close on March 31, 2025. Pursuant to the terms of the Company’s 2023 Equity Plan, a total of 13,776,345 RSUs were awarded to officers, directors, and employees. 9,255,085 of the RSUs were awarded to directors and officers and 4,521,260 were awarded to employees. All RSUs will vest in three equal tranches, on May 16, 2026, May 16, 2027, and May 16, 2028, unless otherwise varied pursuant to the terms of the 2023 Equity Plan.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This management’s discussion and analysis (“MD&A”) of the financial condition and results of operations of Planet 13 is for the three months ended March 31, 2025. It is supplemental to, and should be read in conjunction with, our unaudited condensed interim consolidated financial statements for the three months ended March 31, 2025 and 2024, and the accompanying notes presented herein. Our financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Financial information presented in this MD&A is presented in United States dollars (“$”, “USD” or “US$”), unless otherwise indicated.

In this MD&A, unless the context otherwise requires, the terms “we,” “us,” “our,” “Company,” or “Planet 13” refer to Planet 13 Holdings Inc. together with its wholly owned subsidiaries.

This MD&A contains certain “forward-looking statements” and certain “forward-looking information” as defined under applicable United States and Canadian securities laws. Please refer to the discussion of forward-looking statements and information set out under the heading “Cautionary Note Regarding Forward-Looking Statements,” identified in this Quarterly Report on Form 10-Q. As a result of many factors, our actual results may differ materially from those anticipated in these forward-looking statements and information.

Overview

We are a multi-state cannabis operator with licenses to operate in Nevada, California, Florida, and Illinois.

As of March 31, 2025, we employed approximately 900 full-time and 100 part-time employees and remain focused on providing our customers with the best products, best services, and an experiential shopping experience at our superstore-themed dispensaries, while expanding our products and sales through neighborhood stores. Each of our state operations is held in state-focused subsidiaries: (a) Newtonian Principles, Inc. for California licensed cannabis dispensing and distribution activities, (b) Next Green Wave, LLC for California licensed cannabis cultivation, production and distribution activities, (c) MM Development Company, Inc. for all licensed Nevada cannabis cultivation, production, distribution, and dispensing activities, (d) VidaCann, LLC (“VidaCann”) which holds our Florida Medical Marijuana Treatment Center (“MMTC”) license, and (e) Planet 13 Illinois, LLC (“Planet 13 Illinois”) which holds our Illinois social-equity justice impaired dispensing license. We have focused on our large-store dispensing stores as superstores which offer an experiential approach to our customers, including drones, robotics, 3-D mapping projection, cannabis-culture inspired social-media backdrops for customer interaction, customer facing production, one-on-one sales staffing and customer education, and other interactive marketing elements to differentiate from more traditional dispensing locations, which we refer to herein as “neighborhood stores”. Each of our cannabis facilities is state-licensed as an adult-use cannabis facility, a medical cannabis facility, or a dual-use facility allowing for both adult-use and medical cannabis licensed activity, as designated below in the state-by-state breakdown.

Nevada

As of March 31, 2025, we held the following licensed cannabis operations in Nevada: (a) one dual-licensed dispensary superstore adjacent to the Las Vegas Strip with 24,000 square feet of licensed dispensary (the “Planet 13 Las Vegas Superstore”), (b) one adult-use “neighborhood store” at 2,300 square feet of licensed dispensary (the “Medizin dispensary”), (c) three dual-licensed production facilities, one of which is co-located and customer-facing at the Planet 13 Las Vegas SuperStore with 18,500 square feet of licensed production, (d) three dual-licensed cultivation facilities, one with approximately 16,100 square foot indoor cultivation facility under perpetual harvest cycle, a second with 45,000 square feet co-located with our production license at that facility, and a small-indoor rural site in Beatty, Nevada that is expandable up to 2,300,000 square feet of greenhouse located on 80-acres owned by us, also co-located with our production license at that facility, (e) one cannabis distribution license and (f) one cannabis consumption license operating as Dazed! Consumption Lounge, a 3,000 square foot location inside the Planet 13 Las Vegas Superstore. At the Planet 13 Las Vegas Superstore, we also offer ancillary services to our customers, including a restaurant (currently closed and awaiting a new tenant operator) with a liquor license, a retail store, and our online cannabidiol (“CBD”) store which also sells products in our facility.

California

As of March 31, 2025, we held the following licensed operations in California: (a) an adult-use dispensary superstore co-located with a distribution license at our 33,000 square foot facility in Santa Ana (the “Planet 13 OC Superstore”), and (b) one dual-use and two adult-use cultivation licenses along with a nursery license and distribution license at our 35,000 square foot cultivation facility, and one Type P production license at a 4,000 square foot facility.

Table of Contents

Florida

As of March 31, 2025, we are continuing capital outlays to utilize our Florida MMTC license issued by the Florida Department of Health that was acquired through our acquisition of VidaCann. The VidaCann acquisition added a cultivation and processing facility, a production facility and a 26 retail store network, to which we have added six additional locations, bringing the total number of medical dispensaries we operate in Florida to 32. We also hold a 23-acre parcel of real property, inclusive of a 10,500 square foot building, near Ocala, Florida that is currently listed for sale. The property previously received Florida OMMU approvals for cultivation, processing, and dispensing activities. As of the date of this quarterly report on Form 10-Q, as part of our Florida expansion, we have entered into four leases for additional dispensing locations in Florida, which remain subject to completion of tenant improvements and regulatory inspection prior to sales to customers.

Illinois

As of March 31, 2025 we operate one dispensary in Waukegan, Illinois. The Company has begun to introduce its exclusive brands of products in the Illinois market starting with the HaHa line of infused gummy products currently selling in the Planet 13 Waukegan dispensary. The Company intends to expand the sale of these exclusive products to 3rd party dispensaries in the Illinois market through its wholesale distribution network in the second half of 2025.

Table of Contents

Results of Operations

	Three Months Ended
	March 31,			March 31,			Percentage
*Expressed in USD$*	2025			2024			Change
Revenue
Net revenue		28,031,807			22,877,471			22.5	%
Cost of Goods Sold		(16,024,302	)		(12,392,992	)		29.3	%
Gross Profit		12,007,505			10,484,479			14.5	%
Gross Profit Margin %		42.8	%		45.8	%

Expenses
General and Administrative		14,016,688			10,024,787			39.8	%
Sales and Marketing		1,547,018			1,290,737			19.9	%
Lease expense		1,304,893			774,946			68.4	%
Depreciation and Amortization		1,751,430			2,059,023			(14.9	)%
Total Expenses		18,620,029			14,149,493			31.6	%

Income (Loss) From Operations		(6,612,524	)		(3,665,014	)		80.4	%

Other Income (Expense):
Interest expense, net		(176,411	)		24,562			(818.2	)%
Foreign exchange gain (loss)		(2,889	)		(3,097	)		(6.7	)%
Other income, net		4,978,523			113,749			4276.8	%
Total Other Income		4,799,223			135,214			3449.4	%

Loss for the period before tax		(1,813,301	)		(3,529,800	)		(48.6	)%
Provision for income tax (current and deferred)		(233,866	)		(2,343,969	)		(90.0	)%
Loss for the period		(2,047,167	)		(5,873,769	)		(65.1	)%

Loss per share for the period
Basic and fully diluted income (loss) per share	$	(0.01	)	$	(0.03	)

Weighted Average Number of Shares Outstanding
Basic and diluted		325,261,578			228,437,545

We experienced a $5,154,336 increase in net revenue during the three months ended March 31, 2025 , when compared to the three months ended March 31, 2024. The increase is attributable to the inclusion of the VidaCann operations for a full quarter as a result of the acquisition that closed on May 9, 2024. Results from the VidaCann operations are not included in the results for the three months ended March 31, 2024. We experienced a reduction in the number of customers at our Planet 13 Las Vegas Superstore compared to the prior year, a decrease in revenue from the Planet 13 OC store, relatively flat wholesale revenue from the NGW cultivation operations in California and a decrease in net wholesale revenue in Nevada. Overall, net revenue increased by 22.5% during the three months ended March 31, 2025, when compared to the three months ended March 31, 2024 as a result of the inclusion of the VidaCann operations during the three months ended March 31, 2025. We believe that the potential economic downturn and increase in inflation combined to reduce the disposable income of our customers during the three months ended March 31, 2025, and also had an impact on the number of customers and tourists visiting the Planet 13 Las Vegas Superstore and our other retail locations.

Table of Contents

Details of net revenue by product category are as follows:

	Three Months Ended
	March 31,		March 31,		Percentage
	2025		2024		Change
Flower	$	10,241,007	$	7,230,167		41.6	%
Concentrates		8,712,701		7,021,713		24.1	%
Edibles		4,187,874		3,799,037		10.2	%
Topicals and Other Revenue		1,488,219		986,747		50.8	%
Wholesale		3,402,006		3,839,807		(11.4	)%
Net revenue	$	28,031,807	$	22,877,471		22.5	%

Gross profit margin for the three months ended March 31, 2025, was 42.8% compared to 45.8% for the three months ended March 31, 2024. The decrease in gross profit margin was a result of lower wholesale margins when compared to the three months ended March 31, 2024. Retail operations have an inherently higher gross margin than wholesale operations.

The costs of internal cultivation have continued to trend down as we continue to improve our yields and cultivation efficiency across all of our cultivation facilities. In addition, margin enhancement through the creation of internally generated brands, such as TRENDI, Leaf & Vine, HaHa Gummies, Dreamland Chocolate, HaHa Beverages and Medizin, continued to have a positive impact on gross margins during the three months ended March 31, 2025, helping offset the lower margins received on the sale of wholesale product and sales to local customers in the State of Nevada. The cost of internal cultivation at our VidaCann operations also improved during the three months ended March 31, 2025 as upgrades and efficiency measures implemented have had a positive impact on yields and lower operational costs. We anticipate that margins will trend upward as tourist customers return to Las Vegas and the Planet 13 Las Vegas Superstore in greater numbers and through our ability to grow our Florida retail operations.

Our premium cultivation facilities were operating near capacity during the three months ended March 31, 2025. The amount of cannabis grown during the three months ended March 31, 2025, was in line with the prior year first quarter. Wholesale flower prices continued to be soft in both California and Nevada in the three months ended March 31, 2025. The ongoing price declines that were experienced during 2024 and in the three months ended March 31, 2025 led to an overall decline in wholesale flower revenue during the quarter when compared to the three months ended March 31, 2024.

Table of Contents

Overall gross profit was $12,007,505 and $10,484,479 for the three months ended March 31, 2025 and 2024 respectively, an increase of 14.5%. The increase can be directly attributed. to the inclusion of the VidaCann operations during the three months ended March 31, 2025.

General and Administrative (“G&A”) expenses (which includes non-cash share-based compensation expenses), increased by 39.8% during the three months ended March 31, 2025, when compared to the three months ended March 31, 2024. The increase in G&A expenses incurred was a result of the addition of the VidaCann operations. These increases were partially mitigated by focused cost cutting initiatives undertaken by the Company, coupled with a reduction in share-based compensation expense recorded during the three months ended March 31, 2025 when compared to the three months ended March 31, 2024. Overall, excluding non-cash share-based compensation expenses, G&A expenses as a percentage of revenue equaled 49.8% for the three months ended March 31, 2025, compared to 43.4% for the three months ended March 31, 2024.

A detailed breakdown of G&A expenses is as follows:

	Three Months Ended
	March 31,		March 31,		Percentage
	2025		2024		Change
Salaries and wages	$	5,878,604	$	3,665,242		60.4	%
Share-based compensation expense		60,331		104,338		(42.2	)%
Executive compensation		1,099,940		632,362		73.9	%
Licenses and permits		702,036		561,616		25.0	%
Payroll taxes and benefits		1,387,489		973,275		42.6	%
Supplies and office expenses		329,597		240,820		36.9	%
Subcontractors		635,060		117,219		441.8	%
Professional fees (legal, audit and other)		1,263,506		2,171,039		(41.8	)%
Miscellaneous general and administrative expenses		2,660,125		1,558,876		70.6	%
	$	14,016,688	$	10,024,787		39.8	%

Non-cash, share-based compensation of $60,331 was recognized during the three months ended March 31, 2025, decreasing from $104,338 that was recognized during the three months ended March 31, 2024. The decrease is attributable to the 485,185 Restricted Share Units (“RSUs”) that were granted in the prior year, of which 185,185 vested immediately when compared to 100,000 RSUs that were granted and vested in the three months ended March 31, 2025. These amounts are non-cash, and the expense is recognized in accordance with the vesting schedule of the underlying stock options and RSUs. See Note 12 to our audited consolidated financial statements filed with our Annual Report on Form 10-K for the year ended December 31, 2024, for additional details on the assumptions used to calculate fair value as well as information regarding the vesting of the various components of the non-cash share-based compensation.

Sales and marketing expenses increased by 19.9% or $256,281 during the three months ended March 31, 2025 compared to the three months ended March 31, 2024. The increase was a result of us continuing to refine our marketing efforts to optimize marketing spend on initiatives that drive increased customer traffic to the Planet 13 Las Vegas Superstore and the Planet 13 OC store and our Medizin dispensary in Nevada as well as to support the launch of our Planet 13 Illinois retail dispensary in Waukegan and marketing expenses incurred in Florida promoting our expanded store network.

Table of Contents

Lease expense increased by 68.4% during the three months ended March 31, 2025, when compared to the three months ended March 31, 2024 due to increases in contracted lease rates on the Company’s leased properties during the year as well as the addition of 32 dispensaries, a cultivation and processing facility and a production facility in Florida.

Depreciation and amortization decreased by 14.9% during the three months ended March 31, 2025, when compared to the three months ended March 31, 2024 due to a reduction in the asset base in California after impairment charges in 2024, which included depreciation expense in the prior year.

No impairment charge was incurred during the three months ended March 31, 2025. During the quarter ended March 31, 2024, we recorded an impairment loss of $2,393,087 related to the write-down to net realizable value of construction in process assets for a steel building kit structure at our Florida operations that is no longer going to be used in the operations.

Interest expense of ($176,411) was incurred during the three months ended March 31, 2025, compared to net interest income of $24,562 earned during the three months ended March 31, 2024. Interest income relates to interest earned on cash deposits held by the Company. Interest expense is related to accrued interest on our long-term debt that is due and payable on demand. The balance of long-term debt as of March 31, 2025, was $1,190,957 compared to $1,177,722 as of December 31, 2024.

We conduct our operations in both United States dollars and Canadian dollars, holding financial assets and incurring expenses in both currencies, and holding all of our currency in US dollars. The foreign currency gains/losses reflect fluctuations in the underlying exchange rates on the dates expenses are incurred compared to when they are paid. It is our policy not to hedge our CAD exposure.

Other income (expense), consisting of Automated Teller Machine (“ATM”) fees, and other miscellaneous income/expense, including the recovery of a property in a legal settlement related to the El Capitan matter valued at $4,570,227, was income of $4,978,523 for the three months ended March 31, 2025, compared to other income consisting of ATM fees, and other miscellaneous income/expense of $113,749 for the three months ended March 31, 2024.

Income tax expense for the three months ended March 31, 2025, was $233,866 compared to $2,343,969 for the prior year period. The tax expense increased due to a decrease in the Company's deferred tax valuation allowance during the three months ended March 31, 2025, when compared to the three months ended March 31, 2024. We are subject to Section 280E of the Internal Revenue Code (the “Code”), which prohibits businesses from taking deductions or credits in carrying on any trade or business consisting of trafficking in certain controlled substances that are prohibited by federal law. We, to the extent our “trafficking” activities, and/or key contract counterparties directly engaged in trafficking in cannabis, have incurred significant tax liabilities from the application of Section 280E. Our income tax obligations under Section 280E of the Code are typically substantially higher as compared to companies to which Section 280E does not apply. Section 280E essentially requires us to pay federal, and as applicable, state income taxes on gross profit, which presents a significant financial burden that increases our net loss and may make it more difficult for us to generate net profit and cash flow from operations in future periods. In addition, to the extent that the application of Section 280E creates a financial burden on contract counterparties, such burdens may impact the ability of such counterparties to make full or timely payment to us, which would also have a material adverse effect on our business.

The overall net loss for the three months ended March 31, 2025, was $2,047,167 (($0.01) per share) compared to an overall net loss of $5,873,769 (($0.03) per share) for the three months ended March 31, 2024.

Table of Contents

Segmented Disclosure

The Company determined that each of its locations represents an operating segment. These operating segments have been aggregated into a single reportable segment as the Company operates as a vertically integrated cannabis company with dispensary, cultivation, production and distribution operations in the States of Nevada and Florida, dispensary, cultivation and distribution operations in the State of California and dispensary operations in the State of Illinois.

Liquidity and Capital Resources

As of March 31, 2025, our financial instruments consist of cash, restricted cash, deposits, accounts receivable, accounts payable and accrued liabilities, and notes payable. We have no speculative financial instruments, derivatives, forward contracts, or hedges.

As of March 31, 2025, we have working capital of $26,457,372 compared to working capital of $36,446,097 as of March 31, 2024. The Company believes that it has adequate liquidity in the form of cash on hand to fund all its planned capital expenditures and expansion plans as well as to continue to fund its operation over the next 12 months and the planned build-out of its operations in Florida. The Company currently has two properties for sale; a home in Santa Barbara California and a commercial property in Summerfield, Florida that it expects to have sold in the second half of 2025 with net proceeds in the range of $7M to $8M combined. The Company will use the proceeds to fund operations and expansion in Florida.

The Company entered into a $9,750,000 cash secured revolving line of credit agreement on June 13, 2024, which had no previous draws until the quarter ended March 31, 2025. The existing $3M draw was used to pay off the approximately $3M note payable at Lafayette State Bank that matured on February 20, 2025.

The following table relates to the three months ended March 31, 2025 and 2024:

	Three Months Ended
	March 31,			March 31,
	2025			2024
Cash flows used in operating activities	$	(5,189,040	)	$	(1,430,951	)
Cash flows used in investing activities		(2,691,268	)		(2,942,596	)
Cash flows provided by financing activities		52,368			9,913,856

Cash Flows from Operating Activities

Net cash used in operating activities was $5,189,040 for the three months ended March 31, 2025, compared to cash used in operating activities of $1,430,951 for the three months ended March 31, 2024. A significant portion of the increase in cash used in operating activities is directly attributable to the net change in certain working capital items during the three months ended March 31, 2025, when compared to the three months ended March 31, 2024.

Cash Flows from Investing Activities

Net cash used in investing activities was $2,691,268 for the three months ended March 31, 2025, compared to net cash used in investing activities of $2,942,596 for the three months ended March 31, 2024. Capital expenditures were primarily related to new store buildouts and upgrades to the cultivation facilities in Florida.

Cash Flows from Financing Activities

Net cash provided by financing activities was $52,368 during the three months ended March 31, 2025, compared to net cash provided by financing activities of $9,913,856 for the three months ended March 31, 2024. The increase was a result of the net cash proceeds received on the closing of an equity financing in March 2024.

Capital Resources

We have a recent history of operating losses. It may be necessary for us to arrange for additional financing to meet our ongoing growth initiatives.

Management believes it will be able to raise equity capital as required in the long term, but recognizes the risks attached thereto. There can be no assurance that it will be able to obtain adequate financing in the future or that the terms of such financing may be favorable.

Should financing not be available, the Company has adequate liquidity in the form of cash on hand to fund all of its planned capital expenditures and expansion plans as well as to continue to fund its operation over the next 12 months, including the planned build-out of its operations in Florida.

Table of Contents

Capital Management

Our capital consists of shareholders’ equity. Our objective when managing capital is to maintain adequate levels of funding to support the development of our businesses and maintain the necessary corporate and administrative functions to facilitate these activities. This is done primarily through equity financing. Future financings are dependent on market conditions and there can be no assurance we will be able to raise funds in the future. We invest all capital that is surplus to our immediate operational needs in short-term, highly liquid, and high-grade financial instruments. There were no changes to our approach to capital management during the period. We are not subject to externally imposed capital requirements.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements as of March 31, 2025, or as of the date hereof.

Critical Accounting Estimates

The preparation of consolidated financial statements in conformity with GAAP requires our management to make judgements, estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements. Although these estimates are based on management’s best knowledge of the amounts, events or actions, actual results may differ from those estimates. Estimates and judgements are continuously evaluated and are based on management’s experience and other factors, including expectations of future events that are believed to be reasonable.

Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.

There have been no material changes to our critical accounting estimates as set forth in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2024.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no material changes to our market risk disclosures as set forth in Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2024.

Item 4. Controls and Procedures

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Our management, with the participation of our Co-Chief Executive Officers and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Exchange Act. Based on that evaluation as of March 31, 2025, our Co-Chief Executive Officers and Chief Financial Officer concluded that our Company’s disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, cannot provide absolute assurance of achieving the desired control objectives. Our management recognizes that any control system, no matter how well designed and operated, is based upon certain judgments and assumptions and cannot provide absolute assurance that its objectives will be met. Similarly, an evaluation of controls cannot provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we may become involved in legal or regulatory proceedings, lawsuits and other claims arising in the ordinary course of our business. In view of the inherent difficulty of predicting the outcome of such matters, we cannot state what the eventual outcome of such matters will be. However, based on our knowledge, we are not presently a party to any legal proceedings that, in the opinion of our management, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity and reputational harm, and other factors.

Item 1A. Risk Factors.

In addition to other information set forth in this report, you should carefully consider the risk factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, which could materially affect our business, financial condition, financial results, or future performance. Other than as set forth below, there have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The Company made no unregistered sales of securities during the quarter covered by this report that have not previously been disclosed in a Current Report on Form 8-K.

Item 3. Defaults Upon Senior Securities.

Not applicable.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Insider Trading Arrangements

The Company’s executive officers and directors may from time to time enter into plans or arrangements for the purchase or sale of its common stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. During the three months ended March 31, 2025, no officers or directors of the Company adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K.

Table of Contents

Item 6. Exhibits.

EXHIBIT INDEX

		Incorporated by Reference
Exhibit No.	Description	Form	Exhibit	Filing Date	Filed/Furnished Herewith
31.1	Certification of Principal Executive Officer (Robert Groesbeck) pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				✓
31.2	Certification of Principal Executive Officer (Larry Scheffler) pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				✓
31.3	Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				✓
32.1*	Certification of Principal Executive Officers and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				✓
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)				✓

*The information in this exhibit is furnished and deemed not filed with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is not to be incorporated by reference into any filing of Planet 13 Holdings Inc. under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 14, 2025	By:	/s/ Robert Groesbeck
		Robert Groesbeck
		Co-Chief Executive Officer
		(Principal Executive Officer)

	By:	/s/ Larry Scheffler
		Larry Scheffler
		Co-Chief Executive Officer
		(Principal Executive Officer)

	By:	/s/ Dennis Logan
		Dennis Logan
		Chief Financial Officer
		(Principal Financial and Accounting Officer)